Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

85.40 +0.06 (+0.07%)
Streaming Delayed Price Updated: 11:51 AM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
34 35 Next >
1 Outperformer Poised to Be the Next Stock-Split Stock, and 2 High-Flying Stocks Unlikely to Split Their Shares
While one popular stock looks like a no-brainer split candidate, two other companies, which are seemingly long overdue for a split, are unlikely to take action. 
Via The Motley Fool
How Is The Market Feeling About DexCom?
Via Benzinga
$1000 Invested In DexCom 10 Years Ago Would Be Worth This Much Today
Via Benzinga
What Are the Best Companies to Invest in Now? Our 3 Picks for August
After you after the best companies to invest in? Here are the best picks for the month of August that you can't afford to miss. 
Via InvestorPlace
This Is What Whales Are Betting On DexCom
Via Benzinga
Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move
Even after crushing the market in the past year, these stocks are worth investing in. 
Via The Motley Fool
Why DexCom Shares Are Trading Higher Today
DexCom Inc (NASDAQ: DXCM) shares are trading higher after the company reported  
Via Benzinga
6 Analysts Have This to Say About DexCom
Via Benzinga
DexCom (DXCM) Q2 2023 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2023. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in August and 1 to Avoid Like the Plague
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage, there's one historically cheap industry leader and another outperformer set to face a mountain of... 
Via The Motley Fool
S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best; Medtech Firms Sicken
DexCom and several medical products firms struggled. 
Via Investor's Business Daily
Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher
Strong Q2 earnings performance propelled DexCom higher. Investors cheered the glucose monitoring leader's bullish sales view and international expansion plans. 
Via MarketBeat
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $75,000 Today
Via Benzinga
Looking At DexCom's Recent Unusual Options Activity
Via Benzinga
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report. 
Via Benzinga
Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose... 
Via Benzinga
2 Growth Stocks That Could Double in 5 Years
They could deliver excellent returns well beyond that. 
Via The Motley Fool
A Look Into DexCom Inc's Price Over Earnings
Via Benzinga
Stock Market Rallies Amid Huge Earnings, Fed Rate Hike, Inflation Data: Weekly Review
Despite Thursday's downside reversal, the major indexes had a solid advance. 
Via Investor's Business Daily
Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook
Dexcom stock rose after the company reported Q2 earnings and revenue that topped Wall Street targets and raised full-year sales guidance. 
Via Investor's Business Daily
Dexcom Reports Second Quarter 2023 Financial Results
From DexCom, Inc.
Via Business Wire
Top Picks: 3 Stocks That (Almost) All Analysts Agree On
While you shouldn’t rely on the word of analysts, sometimes they are the best stocks to buy for the long haul. 
Via InvestorPlace
Elliott Wave Technical Analysis: DexCom Inc. - Wednesday, July 19
Looking for longs on the pullback in wave iv. 
Via Talk Markets
Wall Street Believes These High-Profile Stock-Split Stocks Can Lose Up to 91% of Their Value
The low-water price targets provided by select analysts and Wall Street institutions suggest these widely owned stock-split stocks could plunge. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Nvidia And This AI Stock Lead 5 Names Near Buy Points
Nvidia has soared this year. Now its tight range has created a new buy point. 
Via Investor's Business Daily
Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens
This elite eight meet long-term growth criteria for sales and earnings. 
Via Investor's Business Daily
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.